VANCOUVER, BC--(Marketwired - October 13, 2016) - On Friday, Oct. 14, the Fraser Institute will release a new book examining intellectual property rights and pharmaceuticals.
The book, Intellectual Property Rights and the Promotion of Biologics, Medical Devices, and Trade in Pharmaceuticals, spotlights how patent protections around the world affect both innovation and prices of new life-saving and life-extending drugs and medical devices.
A news release with additional information will be issued via Marketwired on Oct. 14 at 5:30 am (Eastern).
MEDIA CONTACTS:
Steven Globerman, Senior Fellow
Fraser Institute
To arrange media interviews or for more information, please contact:
Bryn Weese
Media Relations Specialist, Fraser Institute
(604) 688-0221 ext. 589
bryn.weese@fraserinstitute.org
Follow the Fraser Institute on Twitter | Like us on Facebook
The Fraser Institute is an independent Canadian public policy research and educational organization with offices in Vancouver, Calgary, Toronto, and Montreal and ties to a global network of think-tanks in 87 countries. Its mission is to improve the quality of life for Canadians, their families and future generations by studying, measuring and broadly communicating the effects of government policies, entrepreneurship and choice on their well-being. To protect the Institute's independence, it does not accept grants from governments or contracts for research. Visit www.fraserinstitute.org
Contact Information:
Contact:
Bryn Weese
Media Relations Specialist
Fraser Institute
(604) 688-0221 ext. 589
bryn.weese@fraserinstitute.org